About Event
Why are T-Cell Engagers the Next Frontier in Autoimmune Therapy?
As the autoimmune drug development landscape evolves, the promise of T-cell engagers (TCEs) is becoming impossible to ignore. Unlike cell therapies, TCEs offer a more cost-effective, off-the-shelf option with easier administration and reduced logistical hurdles making them ideal for treating chronic autoimmune diseases.
What began in oncology is now being smartly re-engineered for autoimmunity: optimized CD3 affinities, new strategies to mitigate CRS, and highly selective targeting are paving the way for safer, more durable TCE therapies. But unlocking the full potential of TCEs for autoimmune conditions demands focused, cross-functional collaboration.
That’s where the T-Cell Engager for Autoimmune Disease Summit comes in. This is the only industry meeting solely dedicated to TCEs in autoimmunity bringing together translational scientists, immunology pioneers, and drug development leaders to tackle the specific preclinical, mechanistic, and regulatory hurdles unique to this modality.
Whether you're developing novel formats, exploring new immune targets, or preparing for IND submission, this summit provides the deep technical exchange and curated networking you need to move forward with confidence.
Companies In The Room Include:
Don't miss these highlights from the brightest minds in autoimmunity:
Engineering Smarter TCEs: Learn how developers are reducing immune activation while enhancing precision and tissue penetration.
Expanding Target Space: Uncover novel disease drivers and immune cell populations beyond B cell targets to enable tailored and differentiated therapeutic approaches.
Clinical-Ready Design: Optimize dosing, antagonism, and safety profiles to align with the unique demands of autoimmune diseases and meet the expectations of rheumatologists and regulators.
Real-World Translation: Gain practical insights from top biopharma and academic experts leading the charge on IND-enabling studies, preclinical development, and early-stage trials.
Be part of the only community focused solely on overcoming the challenges and maximizing the opportunity of TCEs in autoimmunity.
